Study protocol for a multi-institutional randomized phase III study comparing combined everolimus plus lanreotide therapy and everolimus monotherapy in patients with unresectable or recurrent gastroenteropancreatic neuroendocrine tumors; Japan Clinical Oncology Group Study JCOG1901 (STARTER-NET study)

Gastroenteropancreatic Neuroendocrine Tumors ◽

Oncology Group Study ◽

Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyy125 ◽

2018 ◽

Cited By ~ 2

Author(s):

Kiyo Tanaka ◽

Nobuhiro Hanai ◽

Junko Eba ◽

Junki Mizusawa ◽

Takahiro Asakage ◽

...

Keyword(s):

Neck Dissection ◽

Clinical Oncology ◽

Tongue Cancer ◽

Stage I ◽

Phase Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Phase Iii Study ◽

Prophylactic Neck Dissection

Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyv213 ◽

2016 ◽

Vol 46 (4) ◽

pp. 385-388 ◽

Cited By ~ 15

Author(s):

Junki Mizusawa ◽

Chigusa Morizane ◽

Takuji Okusaka ◽

Hiroshi Katayama ◽

Hiroshi Ishii ◽

...

Keyword(s):

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine (cape) in patients with stage III colon cancer (CC): Results of Japan Clinical Oncology Group study (JCOG0910).

10.1200/jco.2015.33.15_suppl.3512 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 3512-3512 ◽

Cited By ~ 3

Author(s):

Tetsuya Hamaguchi ◽

Yasuhiro Shimada ◽

Junki Mizusawa ◽

Yusuke Kinugasa ◽

Yukihide Kanemitsu ◽

...

Keyword(s):

Colon Cancer ◽

Adjuvant Chemotherapy ◽

Clinical Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Stage Iii Colon Cancer ◽

Randomized phase III study of etoposide plus cisplatin versus irinotecan plus cisplatin in advanced neuroendocrine carcinoma of the digestive system: A Japan Clinical Oncology Group study (JCOG1213).

10.1200/jco.2015.33.15_suppl.tps4143 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS4143-TPS4143 ◽

Cited By ~ 3

Author(s):

Chigusa Morizane ◽

Nozomu Machida ◽

Yoshitaka Honma ◽

Takuji Okusaka ◽

Narikazu Boku ◽

...

Keyword(s):

Clinical Oncology ◽

Neuroendocrine Carcinoma ◽

Digestive System ◽

Phase Iii ◽

Oncology Group ◽

Oncology Group Study ◽

System A ◽

Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301

International Journal of Hematology ◽

10.1532/ijh97.03115 ◽

2004 ◽

Vol 79 (2) ◽

pp. 165-173 ◽

Cited By ~ 5

Author(s):

Takeaki Takenaka ◽

Kuniaki Itoh ◽

Takayo Suzuki ◽

Atae Utsunomiya ◽

Shin Matsuda ◽

...

Keyword(s):

Multiple Myeloma ◽

Clinical Oncology ◽

Phase Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine in patients with stage III colorectal cancer: Updated results of Japan Clinical Oncology Group study (JCOG0910)

Annals of Oncology ◽

10.1093/annonc/mdx393.012 ◽

2017 ◽

Vol 28 ◽

pp. v163

Author(s):

T. Hamaguchi ◽

Y. Shimada ◽

J. Mizusawa ◽

T. Sato ◽

T. Kato ◽

...

Keyword(s):

Colorectal Cancer ◽

Adjuvant Chemotherapy ◽

Clinical Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113).

10.1200/jco.2014.32.15_suppl.tps4149 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS4149-TPS4149 ◽

Cited By ~ 2

Author(s):

Chigusa Morizane ◽

Takuji Okusaka ◽

Junki Mizusawa ◽

Hiroshi Katayama ◽

Makoto Ueno ◽

...

Keyword(s):

Combination Therapy ◽

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113, FUGA-BT).

10.1200/jco.2018.36.15_suppl.4014 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 4014-4014 ◽

Cited By ~ 4

Author(s):

Makoto Ueno ◽

Chigusa Morizane ◽

Takuji Okusaka ◽

Junki Mizusawa ◽

Hiroshi Katayama ◽

...

Keyword(s):

Combination Therapy ◽

Clinical Oncology ◽

Biliary Tract ◽

Biliary Tract Cancer ◽

Phase Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Tract Cancer ◽

A randomized phase III study of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group study JCOG1610

Annals of Oncology ◽

10.1093/annonc/mdy299.057 ◽

2018 ◽

Vol 29 ◽

pp. viii594-viii595

Author(s):

H. Urakawa ◽

J. Mizusawa ◽

K. Tanaka ◽

J. Eba ◽

H. Hiraga ◽

...

Keyword(s):

Giant Cell Tumor ◽

Giant Cell ◽

Clinical Oncology ◽

Cell Tumor ◽

Phase Iii ◽

Oncology Group ◽

Oncology Group Study ◽

412P Six-year updated results of Japan Clinical Oncology Group study (JCOG0910): Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine in patients with stage III colorectal cancer

Annals of Oncology ◽

10.1016/j.annonc.2020.08.523 ◽

2020 ◽

Vol 31 ◽

pp. S416-S417

Author(s):

T. Hamaguchi ◽

Y. Shimada ◽

J. Mizusawa ◽

Y. Kanemitsu ◽

A. Shiomi ◽

...

Keyword(s):

Colorectal Cancer ◽

Adjuvant Chemotherapy ◽

Clinical Oncology ◽

Phase Iii ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study ◽